Ugeskr Laeger. 2007 Nov 12;169(46):3971-4.

[Quadrivalent HPV 6/11/16/18 vaccine].

[Article in Danish]

Kjaer SK, Andersen ES, Djursing H, Hansen T, Jørgensen JJ, Nilas L, Ottesen BS, Petersen LK, Thomsen SG, Toftager-Larsen K.

Source

Rigshospitalet, Juliane Marie Center, Kraeftens Bekaempelse, Institut for Epidemiologisk Kraeftforskning, Aalborg Sygehus. susanne@cancer.dk

Abstract

This randomized, double-blind study included 12,167 women who received three doses of quadrivalent HPV 6/11/16/18 vaccine or placebo (day 1, month 2, and month 6). The participants were followed for an average of 3 years. The vaccine prevented 98% of CIN2, CIN3 and adenocarcinoma in situ related to HPV 16 or HPV 18 among women not previously exposed to these types, and 44% among all women (i.e. both those with and without previous infection). The vaccine efficacy against all high-grade cervical lesions, independent of causal HPV type, was estimated to 17%.

Republished from

N Engl J Med. 2007 May 10;356(19):1915-27.

PMID:: 18078651; [PubMed]

Publication Types

English Abstract

Supplemental Content

Save items

Related citations in PubMed

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial. [Lancet. 2009]
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.
Muñoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, Clavel C, Luna J, Myers E, Hood S, et al. Lancet. 2009 Jun 6; 373(9679):1949-57. Epub 2009 Jun 1.
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. [J Infect Dis. 2009]
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years.
Wheeler CM, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, Brown DR, Koutsky LA, Tay EH, García P, et al. J Infect Dis. 2009 Apr 1; 199(7):936-44.
Review Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine. [Int J Infect Dis. 2007]
Review Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine.
Villa LL. Int J Infect Dis. 2007 Nov; 11 Suppl 2:S17-25.
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects. [Int J Gynecol Cancer. 2008]
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjects.
Kang S, Kim KH, Kim YT, Kim YT, Kim JH, Song YS, Shin SH, Ryu HS, Han JW, Kang JH, et al. Int J Gynecol Cancer. 2008 Sep-Oct; 18(5):1013-9. Epub 2007 Nov 6.
Review Human papillomavirus disease and vaccines. [Am J Health Syst Pharm. 2008]
Review Human papillomavirus disease and vaccines.
Hutchinson DJ, Klein KC. Am J Health Syst Pharm. 2008 Nov 15; 65(22):2105-12.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

[Quadrivalent HPV 6/11/16/18 vaccine].
[Quadrivalent HPV 6/11/16/18 vaccine].
Ugeskr Laeger. 2007 Nov 12 ;169(46):3971-4.

PubMed
Mobile phone short message service messaging for behaviour modification in a com...
Mobile phone short message service messaging for behaviour modification in a community-based weight control programme in Korea.
J Telemed Telecare. 2007 ;13(8):416-20.

PubMed
X-ray solution scattering (SAXS) combined with crystallography and computation: ...
X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution.
Q Rev Biophys. 2007 Aug ;40(3):191-285.

PubMed
[A case report: septicemia caused by Mycobacterium tuberculosis in a patient inf...
[A case report: septicemia caused by Mycobacterium tuberculosis in a patient infected with the human immunodeficiency virus in Burundi].
Bull Soc Pathol Exot. 1991 ;84(4):362-4.

PubMed
Dimerisation of HIV-2 genomic RNA is linked to efficient RNA packaging, normal p...
Dimerisation of HIV-2 genomic RNA is linked to efficient RNA packaging, normal particle maturation and viral infectivity.
Retrovirology. 2007 Dec 13 ;4:90.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

[Quadrivalent HPV 6/11/16/18 vaccine].

Source

Abstract

Republished from

Publication Types

Publication Types

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information